Member Info for GaiasKidney

Hi O&T Yes the gearing is now eye-wateringly impressive, however that has to be balanced against the very short life left - expire end June - and the large spread on the subs, presently 7.5 - 12.5, bid was 5 earlier on. The underlying is ~925 - 928 on the most recent trades, so with the exercise price being 915p the subs are moving over to a discount (sub + ex price < underlying price). Even with further rises in the underlying I would still expect a persisting discount as few will want to hold to expiry as that will mean either exercising (very large cash outlay) or hoping the company will offer post expiry settlement (I can find no commitment on that) and the other factor being the large spread. Despite all that there is distinct value at risk here with as said if there is a 5% lift in the underlying that would take that price to ~ 58p over the ex. If we get that 50p for selling subs before the wind up looks feasible. 4x. 10% gives ~9x. If JMI instead holds at the present sp or falls, don't be surprised at wipe out of the subs. I hold a few and am hopeful. Horse race territory now. ATB. GK.

Morning All. RNSs out today. Much on the progress at Wells and the significant potential of Ballard. Also more development cash raised in Aus. What stands out with this for me is the potential rapidity toward design production and in a region of rapidly growing SOP demand presently gripped by China. Far quicker to production than other projects can likely achieve with highly rated non chloride K. GK.

Slight error to those sums:- Sxx Mcap ~$1300m so earnings/Mcap ~ 0.7. So4 ratio ~ 3 1/2 x higher. Very thinly traded share. GK.

I noted your brief foray from your rather lonely furrow here onto the Sxx forum - and the lack of any analysis within the (muted) responses ;-)....It'll be their loss I'm thinking. In my analysis So4 has a very good chance and compared to the Sirius Woodsmith development, the time and cost at Goldfields before getting to actual cash flow generation are materially lower, however Sirius does have the potential to have larger multi billion sales in time. A quick comparative sum, rough estimates: So4 Mcap ~$50m, potential earnings at projected production 400k(550 sale price - 250 opex) = $120/y, 2.4x Mcap; Sxx Mcap ~$1000m, potential earnings at projected production 10m(130 sale price - 40 opex) = $900/y, 0.9x Mcap. Also So4 should get to a position of full production (assuming financed, likely dilution) some 3y before Sirius I would think. I hold both. I see it as more likely that So4 will get taken out pre production though. AIMO. ATB. GK.

$200k contract RNS. GK.

This share appears high up on many stock screening algorithms, particularly for value, momentum and consistant growth. See http://uk.advfn.com/cmn/fbb/thread.php3?id=34631902&from=1&to=496 GK.

Smaller cos in Japan is one of the few areas where there is growth. With a low yen, cheaper energy and nacent signs of China recovery, this growth could continue. The sub shares appear very atractive. I hold. GK.